Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas

BACKGROUND: Glioblastomas progress rapidly making response evaluation using MRI insufficient since treatment effects are not detectable until months after initiation of treatment. Thus, there is a strong need for supplementary biomarkers that could provide reliable and early assessment of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Mörén, Lina, Wibom, Carl, Bergström, Per, Johansson, Mikael, Antti, Henrik, Bergenheim, A. Tommy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818859/
https://www.ncbi.nlm.nih.gov/pubmed/27039175
http://dx.doi.org/10.1186/s13014-016-0626-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818859/
https://www.ncbi.nlm.nih.gov/pubmed/27039175
http://dx.doi.org/10.1186/s13014-016-0626-6

Ejemplares similares